Skip to content

The Effect of Mixed Reality-Based Preoperative Visits on Preoperative Anxiety and Postoperative Pain in Patients Undergoing Elective Laparoscopic Surgery

A Clinical Study of the Effect of Preoperative Visits Based on Mixed Reality Technology on Preoperative Anxiety and Postoperative Pain in Patients Undergoing Elective Laparoscopic Surgery: A Single-center, Randomized, Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106996
Enrollment
Unknown
Registered
2025-08-01
Start date
2025-08-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

Intervention Group:In the experimental group, the MR device is worn in an eyeglasses-style manner. The therapeutic MR content, developed by Suzhou Reco Medical Technology Co., Ltd., comprises four mod
concurrently, the MR relaxation therapy guides patients to interact with virtual environments within tailored MR scenarios, facilitating achievement of psychophysiological relaxation states.
Control Group:Participants in the control arm underwent standard preoperative consultations delivered exclusively through in-person verbal communication.

Sponsors

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Provide written informed consent voluntarily 2. Aged 25–75 years (inclusive) at enrollment 3. Scheduled for elective laparoscopic abdominal surgery (e.g., cholecystectomy, appendectomy) 4. Classified as ASA class II or III 5. Free from: Clinically significant head trauma (per medical records) ; Stereoscopic vision deficits ; Severe hearing loss.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment (MMSE score =4) at screening 4. Documented photosensitivity or screen intolerance 5. Prior exposure to MR/VR/AR devices within 6 months 6. Concurrent enrollment or recent completion (<=3 months) of an interventional clinical trial.

Design outcomes

Primary

MeasureTime frame
Numeric Rating ;

Countries

China

Contacts

Public ContactMao Yanfei

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

maoyanfei1979@163.com+86 152 1435 9001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026